Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, September 18, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Luminex Announces Norovirus as a Launch Menu Assay for ARIES™
Thursday, April 24, 2014
Assay is designed to test for both GI and GII genogroups.

Bio-Rad’s Droplet Digital™ PCR Technology Highlighted at the 2014 AACR Annual Meeting
Tuesday, April 08, 2014
Introduced less than three years ago, ddPCR is rapidly gaining acceptance within the cancer research community. In fact, from 2012 to 2013, the number of cancer research papers involving ddPCR has nearly quintupled.

Eppendorf Launches its New Spring 2014 Advantage Offer
Saturday, April 05, 2014
New offer enables customers to purchase products at favourable prices.

Bio-Rad Launches Precision Blue™ Real-Time PCR Dye
Friday, April 04, 2014
Bio-Rad Laboratories, Inc. today announced the launch of its Precision Blue real-time PCR dye, making it easier for researchers to set up real-time PCR (qPCR) experiments.

Promega Introduces Maxwell 16 LEV RNA FFPE Kit
Tuesday, April 01, 2014
New kit provides high yield, pure and amplifiable RNA from FFPE mammalian tissue samples.

Identifying Epigenetic Biomarkers for Prostate Cancer
Tuesday, April 01, 2014
IDT qPCR assays and probes facilitate the development of predictive epigenetic biomarkers.

Techne’s New In Situ Hybridization Adapter
Friday, March 28, 2014
Delivers a quick, economical solution for 96-well thermal cycler owners.

New Open Access Platform Desktop Spotter To Be Unveiled At Analytica in Germany
Thursday, March 27, 2014
Poly-Pico Technologies Ltd. are showcasing their new open access platform desktop ‘Pico Spotter™’ at Analytica Munich in Germany next month.

TATAA and MultiD Launch GenEx 6
Saturday, March 15, 2014
The software most compliant with guidelines for the analysis of real-time PCR data.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 583
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv